Target intelligence / Profile preview

Glycolysis pathway, anaerobic

Molecular classification
Other (Metabolic pathway), Composed of enzymes, e.g. hexokinase, phosphofructokinase, pyruvate kinase, lactate dehydrogenase
01

Overview

Anaerobic glycolysis is a biochemical pathway in which glucose is converted to pyruvate in the absence of oxygen, and pyruvate is subsequently reduced to lactate, regenerating NAD⁺ required for glycolysis to continue. This process provides a rapid but inefficient means (2 net ATP per glucose) of generating ATP compared to aerobic respiration, which can yield up to 32 ATP per glucose. Anaerobic glycolysis is especially important when oxygen is limited, such as during intense exercise, in red blood cells (which lack mitochondria), and under various pathological conditions. The pathway operates in the cytoplasm and includes multiple enzyme-catalyzed steps, with essential regulatory control points at hexokinase, phosphofructokinase, and pyruvate kinase. The final conversion of pyruvate to lactate is catalyzed by lactate dehydrogenase.

Other names
Anaerobic glycolysisLactic acid fermentation pathway (in animals)Embden–Meyerhof–Parnas pathway (sometimes used broadly for glycolysis itself)
02

Mechanism of action

Enzyme inhibition (blocking specific glycolytic enzymes) Depletion of pathway intermediates (rare and primarily research tools)

03

Biological functions

ATP generation under low oxygen/anaerobic conditionsRegeneration of NAD⁺ (NAD+)Short-term energy production (especially in muscle and erythrocytes)
04

Disease associations

Cancer (many tumors rely on anaerobic glycolysis even when oxygen is present, "Warburg effect")Ischemic conditions (e.g., stroke, heart attack, where tissue oxygen is limited)Inherited glycolytic enzyme deficiencies (rare metabolic diseases)
05

Safety considerations

Systemic inhibition potentially leads to hypoglycemia, tissue energy failure, and lactic acidosisNon-specific inhibition can affect normal tissues, especially brain and red blood cells
06

Interacting drugs

Arsenate (inhibits steps in glycolysis)

3 more in the full profile.

07

Biomarkers

Lactate levels (indicator of tissue hypoxia/anaerobic glycolysis)NAD+/NADH ratio (indirect marker)Glucose consumption rates (in cancer diagnosis, e.g., PET scans)

Beyond the preview

Go deeper on Glycolysis pathway, anaerobic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycolysis pathway, anaerobic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call